Physician profile
Jane P Brunner
NPI 1417944836
$2,958.74
in general payments reported to CMS, 2019-2025
39 companies · $28.04 in 2025
The $28.04 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2021: $190 · 2022: $692 · 2023: $1,226 · 2024: $543 · 2025: $28.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $703.13 | 2021-2024 | Ubrelvy, Linzess, Viberzi |
| Novo Nordisk INC | $385.11 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $228.63 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Supernus Pharmaceuticals, INC. | $157.79 | 2023 | Qelbree |
| Amgen INC. | $156.71 | 2019-2023 | Repatha, Otezla |
| Pfizer INC. | $151.07 | 2019-2024 | |
| Glaxosmithkline, LLC. | $124.61 | 2021-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $93.52 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.15 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $72.20 | 2019-2024 | Breztri, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $71.61 | 2019-2024 | Trintellix |
| Merck Sharp & Dohme LLC | $66.37 | 2022-2024 | Dificid |
| Biohaven Pharmaceuticals, INC. | $63.58 | 2021 | |
| Sumitomo Pharma America, INC. | $48.77 | 2023-2024 | Gemtesa |
| Mylan Specialty L.P. | $48.18 | 2023-2024 | Yupelri |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.